Department of Orthopaedic Surgery, Whangarei Hospital, Whangarei, New Zealand.
Department of Orthopaedic Surgery, Whangarei Hospital, Whangarei, New Zealand.
J Shoulder Elbow Surg. 2022 Apr;31(4):799-805. doi: 10.1016/j.jse.2021.09.006. Epub 2021 Oct 14.
Reverse total shoulder arthroplasty (RTSA) was traditionally reserved for the patient with rotator cuff tear arthropathy. As the indications for RTSA continue to expand, the role of RTSA in patients aged >70 years with glenohumeral arthritis and an intact rotator cuff remains unclear.
To study the New Zealand Joint Registry (NZJR) and compare the outcomes of a primary Total Shoulder Arthroplasty (TSA), a primary RSA and an RSA performed for revision of a failed TSA in patients aged >70 years, to determine if there is clear evidence to support a primary RSA in those aged >70 years instead of a primary TSA METHOD: This is a retrospective study of the NZJR from 2000 to 2018. We included all primary TSAs, primary RTSAs, and those RTSAs that were performed for the revision of a failed TSA. We excluded those RTSAs that were performed for the revision of an RTSA or hemiarthroplasty. The primary outcome was the Oxford Shoulder Score (OSS) at 6 months and 5 years, with a secondary outcome being the subsequent revision rate.
A total of 3449 primary TSAs, 4681 primary RTSAs, and 104 revision RTSAs were identified. The mean OSSs at 6 months for a primary TSA, a primary RTSA, and a revision RTSA were 39.5 ± 9.0, 35.5 ± 9.4, and 32.5 ± 9.7, respectively (P < .001, primary TSA vs. primary RSTA; P <.001, primary TSA vs. revision RTSA; P = .0252 primary RTSA vs. revision RTSA). The mean OSSs at 5 years for a primary TSA and a primary RTSA were 42.1 ± 7.5 vs. 39.8 ± 8.4, respectively (P < .001), with no results available for revision RTSA. The secondary outcome was the revision rate for those aged >70 years with osteoarthritis as their primary indication for surgery. The revision rates for a primary TSA and a primary RTSA were 0.53/100 component-years (95% confidence interval [CI] 0.38-0.72) and 0.51/100 component-years (95% CI 0.31-0.79), respectively (P = .193), which was not statistically significant.
The TSA remains the gold standard for primary shoulder arthroplasty. For those individuals aged >70 years with osteoarthritis as their primary diagnosis, a primary TSA is associated with a higher OSS than and similar revision rates to a primary RTSA's. However, these patients must be counseled regarding the risk of subsequent cuff failure, as the outcomes from a revision RTSA are significantly inferior than those from a primary RTSA.
反向全肩关节置换术(RTSA)传统上仅适用于肩袖撕裂性关节炎患者。随着 RTSA 适应证的不断扩大,对于肩袖完整的 >70 岁肩关节炎患者,RTSA 的作用仍不明确。
研究新西兰关节登记处(NZJR),比较 >70 岁患者初次全肩关节置换术(TSA)、初次反式肩关节置换术(RSA)和因初次 TSA 失败而进行的 RSA 的结果,以确定是否有明确的证据支持在 >70 岁患者中进行初次 RSA 而不是初次 TSA。
这是对 2000 年至 2018 年 NZJR 的回顾性研究。我们纳入了所有初次 TSA、初次 RSA 和因初次 TSA 失败而进行的 RSA。我们排除了因 RSA 或半肩关节置换术失败而进行的 RSA。主要结局是 6 个月和 5 年时的牛津肩关节评分(OSS),次要结局是随后的翻修率。
共确定了 3449 例初次 TSA、4681 例初次 RSA 和 104 例翻修 RSA。初次 TSA、初次 RSA 和翻修 RSA 的 6 个月时 OSS 平均值分别为 39.5 ± 9.0、35.5 ± 9.4 和 32.5 ± 9.7(P <.001,初次 TSA 比初次 RSA;P <.001,初次 TSA 比翻修 RSA;P =.0252 初次 RSA 比翻修 RSA)。初次 TSA 和初次 RSA 的 5 年时 OSS 平均值分别为 42.1 ± 7.5 和 39.8 ± 8.4(P <.001),翻修 RSA 的结果不可用。次要结局是初次 TSA 和初次 RSA 中因骨关节炎作为主要手术适应证的 >70 岁患者的翻修率。初次 TSA 和初次 RSA 的翻修率分别为 0.53/100 个组件年(95%置信区间[CI] 0.38-0.72)和 0.51/100 个组件年(95% CI 0.31-0.79)(P =.193),差异无统计学意义。
TSA 仍然是初次肩关节置换术的金标准。对于因骨关节炎作为主要诊断而 >70 岁的患者,初次 TSA 的 OSS 高于初次 RSA,且与初次 RSA 的翻修率相似。然而,这些患者必须接受有关后续肩袖失败风险的咨询,因为翻修 RSA 的结果明显劣于初次 RSA。